Asana (ASAN) 10-Q 3 Sep 24 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2024	Aug. 27, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2024
Document Transition Report	false
Entity File Number	001-39495
Entity Registrant Name	Asana, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3912448
Entity Address, Address Line One	633 Folsom Street, Suite 100
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	525-3888
Title of 12(b) Security	Class A Common Stock, $0.00001 par value per share
Trading Symbol	ASAN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001477720
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		142,677,666
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		85,486,680

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 219,400	$ 236,663
Marketable securities	302,224	282,801
Restricted cash	455	0
Accounts receivable, net	65,066	88,327
Prepaid expenses and other current assets	53,194	51,925
Total current assets	640,339	659,716
Property and equipment, net	95,742	96,543
Operating lease right-of-use assets	182,261	181,731
Other assets	27,034	23,970
Total assets	945,376	961,960
Current liabilities
Accounts payable	13,834	6,907
Accrued expenses and other current liabilities	72,598	75,821
Deferred revenue, current	285,508	265,306
Operating lease liabilities, current	21,200	19,179
Total current liabilities	393,140	367,213
Term loan, net	41,142	43,618
Deferred revenue, noncurrent	3,684	5,916
Operating lease liabilities, noncurrent	212,855	215,084
Other liabilities	2,638	3,733
Total liabilities	653,459	635,564
Commitments and contingencies (Note 7)
Stockholders' equity
Common stock	2	2
Additional paid-in capital	1,942,911	1,821,216
Accumulated other comprehensive loss	(778)	(236)
Accumulated deficit	(1,650,218)	(1,494,586)
Total stockholders’ equity	291,917	326,396
Total liabilities and stockholders’ equity	$ 945,376	$ 961,960

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Income Statement [Abstract]
Revenues	$ 179,212	$ 162,455	$ 351,660	$ 314,866
Cost of revenues	19,987	16,232	37,791	31,079
Gross profit	159,225	146,223	313,869	283,787
Operating expenses:
Research and development	91,151	84,371	173,942	160,687
Sales and marketing	108,649	96,448	212,981	189,685
General and administrative	36,222	38,787	69,912	72,043
Total operating expenses	236,022	219,606	456,835	422,415
Loss from operations	(76,797)	(73,383)	(142,966)	(138,628)
Interest income and other income (expense), net	6,760	4,165	11,120	9,831
Interest expense	(955)	(968)	(1,897)	(1,935)
Loss before provision for income taxes	(70,992)	(70,186)	(133,743)	(130,732)
Provision for income taxes	1,197	1,228	2,168	2,150
Net loss	$ (72,189)	$ (71,414)	$ (135,911)	$ (132,882)
Net loss per share:
Basic (in dollars per share)	$ (0.31)	$ (0.33)	$ (0.59)	$ (0.61)
Diluted (in dollars per share)	$ (0.31)	$ (0.33)	$ (0.59)	$ (0.61)
Weighted-average shares used in calculating net loss per share:
Basic (in shares)	229,760	219,004	228,430	217,730
Diluted (in shares)	229,760	219,004	228,430	217,730

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (72,189)	$ (71,414)	$ (135,911)	$ (132,882)
Other comprehensive loss:
Net unrealized gains (losses) on marketable securities	1,413	(1,469)	38	(1,015)
Change in foreign currency translation adjustments	281	467	(580)	571
Comprehensive loss	$ (70,495)	$ (72,416)	$ (136,453)	$ (133,326)

CONDENSED CONSOLIDATED STATMENT

CONDENSED CONSOLIDATED STATMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023		214,293
Beginning balance at Jan. 31, 2023	$ 356,574	$ 2	$ 1,595,001	$ (873)	$ (1,237,556)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)		1,371
Issuance of common stock upon the exercise of options	3,073		3,073
Vesting of early exercised stock options	106		106
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		3,484
Issuance of common stock upon the vesting and settlement of restricted stock units	(7)		(7)
Issuance of common stock under employee share purchase plan (in shares)		458
Issuance of common stock under employee share purchase plan	8,558		8,558
Stock-based compensation expense	99,275		99,275
Net unrealized gains (losses) on marketable securities	(1,015)			(1,015)
Foreign currency translation adjustments	571			571
Net loss	(132,882)				(132,882)
Ending balance (in shares) at Jul. 31, 2023		219,606
Ending balance at Jul. 31, 2023	334,253	$ 2	1,706,006	(1,317)	(1,370,438)
Beginning balance (in shares) at Apr. 30, 2023		216,776
Beginning balance at Apr. 30, 2023	348,085	$ 2	1,647,422	(315)	(1,299,024)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)		578
Issuance of common stock upon the exercise of options	1,275		1,275
Vesting of early exercised stock options	32		32
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		2,252
Issuance of common stock upon the vesting and settlement of restricted stock units	(7)		(7)
Stock-based compensation expense	57,284		57,284
Net unrealized gains (losses) on marketable securities	(1,469)			(1,469)
Foreign currency translation adjustments	467			467
Net loss	(71,414)				(71,414)
Ending balance (in shares) at Jul. 31, 2023		219,606
Ending balance at Jul. 31, 2023	334,253	$ 2	1,706,006	(1,317)	(1,370,438)
Beginning balance (in shares) at Jan. 31, 2024		224,728
Beginning balance at Jan. 31, 2024	$ 326,396	$ 2	1,821,216	(236)	(1,494,586)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)	673	673
Issuance of common stock upon the exercise of options	$ 2,129		2,129
Repurchases and retirement of common stock (in shares)		(1,446)
Repurchases and retirement of common stock	(19,721)				(19,721)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		4,880
Issuance of common stock upon the vesting and settlement of restricted stock units	(4)		(4)
Issuance of common stock under employee share purchase plan (in shares)		654
Issuance of common stock under employee share purchase plan	8,866		8,866
Stock-based compensation expense	110,704		110,704
Net unrealized gains (losses) on marketable securities	38			38
Foreign currency translation adjustments	(580)			(580)
Net loss	(135,911)				(135,911)
Ending balance (in shares) at Jul. 31, 2024		229,489
Ending balance at Jul. 31, 2024	291,917	$ 2	1,942,911	(778)	(1,650,218)
Beginning balance (in shares) at Apr. 30, 2024		228,036
Beginning balance at Apr. 30, 2024	319,897	$ 2	1,880,675	(2,472)	(1,558,308)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)		321
Issuance of common stock upon the exercise of options	1,044		1,044
Repurchases and retirement of common stock (in shares)		(1,446)
Repurchases and retirement of common stock	(19,721)				(19,721)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		2,578
Issuance of common stock upon the vesting and settlement of restricted stock units	0
Stock-based compensation expense	61,192		61,192
Net unrealized gains (losses) on marketable securities	1,413			1,413
Foreign currency translation adjustments	281			281
Net loss	(72,189)				(72,189)
Ending balance (in shares) at Jul. 31, 2024		229,489
Ending balance at Jul. 31, 2024	$ 291,917	$ 2	$ 1,942,911	$ (778)	$ (1,650,218)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities
Net loss	$ (135,911)	$ (132,882)
Adjustments to reconcile net loss to net cash provided by operating activities:
Allowance for expected credit losses	372	1,389
Depreciation and amortization	8,293	6,876
Amortization of deferred contract acquisition costs	12,493	10,303
Stock-based compensation expense	108,747	97,703
Net accretion of discount on marketable securities	(3,556)	(932)
Non-cash lease expense	8,888	10,044
Impairment of long-lived assets	0	5,009
Amortization of discount on revolving credit facility and term loan issuance costs	61	60
Changes in operating assets and liabilities:
Accounts receivable	22,914	14,658
Prepaid expenses and other current assets	(13,598)	(9,057)
Other assets	(3,081)	1,348
Accounts payable	6,369	(3,245)
Accrued expenses and other liabilities	(6,373)	(14,217)
Deferred revenue	17,970	27,536
Operating lease liabilities	(9,628)	(8,954)
Net cash provided by operating activities	13,960	5,639
Cash flows from investing activities
Purchases of marketable securities	(107,126)	(139,294)
Maturities of marketable securities	91,296	18,141
Purchases of property and equipment	(2,692)	(5,966)
Capitalized internal-use software costs	(2,783)	(2,348)
Net cash used in investing activities	(21,305)	(129,467)
Cash flows from financing activities
Repayment of term loan	(1,250)	(1,875)
Repurchases of common stock	(19,022)	0
Proceeds from exercise of stock options	2,129	3,073
Proceeds from employee stock purchase plan	8,866	8,558
Taxes paid related to net share settlement of equity awards	(4)	(7)
Net cash provided by (used in) financing activities	(9,281)	9,749
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash	(182)	1,213
Net decrease in cash, cash equivalents, and restricted cash	(16,808)	(112,866)
Cash, cash equivalents, and restricted cash
Beginning of period	236,663	526,563
End of period	219,855	413,697
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents	219,400	413,697
Restricted cash	455	0
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows	219,855	413,697
Supplemental cash flow data
Cash paid for income taxes	2,587	2,426
Supplemental non-cash investing and financing information
Purchase of property and equipment in accounts payable and accrued expenses	447	1,082
Stock-based compensation expense capitalized for software development	1,953	1,570
Repurchases of common stock in accrued liabilities	$ 698	$ 0

Organization

Organization	6 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Organization and Description of Business Asana, Inc. (“Asana” or the “Company”) was incorporated in the state of Delaware on December 16, 2008. Asana is a leading work management software platform with an enterprise focus that helps organizations orchestrate work, from daily tasks to cross-functional strategic initiatives. The Company is headquartered in San Francisco, California.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and include the accounts of the Company’s wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated on consolidation. The unaudited condensed consolidated balance sheet as of January 31, 2024 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management's opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to state fairly the balance sheet, statements of comprehensive loss, and stockholders' equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K filed with the SEC on March 14, 2024. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Estimates and assumptions reflected in the condensed consolidated financial statements include, but are not limited to, revenue recognition, the useful lives and carrying values of long-lived assets, the fair value of common stock for periods prior to the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“NYSE”) (the “Direct Listing”), stock-based compensation expense, the period of benefit for deferred contract acquisition costs, income taxes, and the valuation of right-of-use assets. Actual results could differ from those estimates. Risks and Uncertainties Global macroeconomic events including inflation, elevated interest rates, bank failures, supply chain disruptions, fluctuations in currency exchange rates, and global armed conflicts, including between Ukraine and Russia and in the Middle East, have led to economic uncertainty. These macroeconomic conditions have and are likely to continue to have adverse effects on the rate of global IT spending, including the buying patterns of the Company’s customers and prospective customers. The conditions caused by the aforementioned macroeconomic events have affected and could continue to affect the rate of global IT spending and could adversely affect demand for the Company’s platform, lengthen the Company’s sales cycles, reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of the Company’s paying customers to go out of business, and affect contraction or attrition rates of the Company’s customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance related to the aforementioned macroeconomic events that would require it to update its estimates or judgments or adjust the carrying value of its assets or liabilities. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements. Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company deposits its cash and cash equivalents with financial institutions that management believes are of high credit quality, although such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Cash equivalents are invested in highly rated securities. The Company grants credit to customers in the normal course of business. For the three and six months ended July 31, 2024 and 2023, there were no individual customers that accounted for 10% or more of the Company’s revenues. No customer accounted for more than 10% of accounts receivable as of July 31, 2024 or January 31, 2024. Fair Value of Financial Instruments Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value is estimated by utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1—Observable inputs comprised of quoted prices for identical assets or liabilities in active markets. Level 2—Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3—Unobservable inputs in which there is little or no market data and that are significant to the fair value of the assets or liabilities. In determining fair value, a financial instrument’s classification within the three-tier fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. The carrying amount of certain financial instruments, including accounts receivable, accounts payable, and accrued liabilities approximates their fair values due to their short-term nature. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates fair value. The Company holds restricted cash for the future payment of voluntary disability insurance claims. The Company had $0.5 million of restricted cash as of July 31, 2024 and no restricted cash as of January 31, 2024. Available-for-sale Investments The Company’s marketable securities are primarily comprised of U.S. government securities, commercial paper, corporate bonds, and agency bonds. The Company classifies its securities as available-for-sale at the time of purchase and reevaluates such classification at each balance sheet date. The Company may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies its marketable securities, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets. Available-for-sale securities are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity until realized. Unrealized gains and losses for any marketable securities that management intends to sell or is more likely than not that management will be required to sell prior to their anticipated recovery are recorded in other income (expense), net. Impairment of Long-Lived Assets The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such asset groups may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. The Company recorded no impairment charge during the three and six months ended July 31, 2024. The Company recorded an impairment charge of $5.0 million during the three and six months ended July 31, 2023, related to the right-of-use (“ROU”) assets and underlying property and equipment associated with its subleased office spaces, which is further described in Note 8. Leases to the condensed consolidated financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The new standard will be effective for the Company for the annual periods beginning February 1, 2024, and for interim periods beginning February 1, 2025. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption of the standard on disclosures within its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The guidance is effective for the Company’s fiscal years beginning after February 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adoption of the standard on its consolidated financial statements.

Revenues

Revenues	6 Months Ended
	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenues	Revenues Deferred Revenue and Remaining Performance Obligations The Company recognized $76.7 million and $65.6 million of revenues during the three months ended July 31, 2024 and 2023, respectively, that were included in the deferred revenue balances at January 31, 2024 and 2023, respectively. The Company recognized $194.1 million and $166.1 million of revenues during the six months ended July 31, 2024 and 2023, respectively, that were included in the deferred revenue balances at January 31, 2024 and 2023, respectively. Deferred revenue that will be recognized within the next twelve months is recorded as current deferred revenue, and the remaining portion is recorded as noncurrent. As of July 31, 2024, the Company's remaining performance obligations from contracts with customers was $394.5 million, of which the Company expects to recognize approximately 83% as revenues over the next 12 months and the remainder thereafter. Deferred Contract Acquisition Costs Deferred contract acquisition costs are amortized over a period of benefit of three years. The period of benefit was estimated by considering factors such as historical customer attrition rates, the useful life of the Company’s technology, and the impact of competition in the software-as-a-service industry. The following table summarizes the activity of deferred contract acquisition costs (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Beginning balance $ 38,940 $ 37,338 $ 39,381 $ 36,583 Capitalization of contract acquisition costs 6,865 6,430 12,511 12,056 Amortization of deferred contract acquisition costs (6,406) (5,432) (12,493) (10,303) Ending balance $ 39,399 $ 38,336 $ 39,399 $ 38,336 Deferred contract acquisition costs, current $ 22,150 $ 20,110 $ 22,150 $ 20,110 Deferred contract acquisition costs, noncurrent 17,249 18,226 17,249 18,226 Total deferred contract acquisition costs $ 39,399 $ 38,336 $ 39,399 $ 38,336 Deferred contract acquisition costs, current is presented within prepaid expenses and other current assets in the condensed consolidated balance sheets. Deferred contract acquisition costs, noncurrent is presented within other assets in the condensed consolidated balance sheets.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes, for assets measured at fair value, the respective fair value and classification by level of input within the fair value hierarchy (in thousands): July 31, 2024 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 84,278 $ — $ — $ 84,278 Total cash equivalents $ 84,278 $ — $ — $ 84,278 Marketable securities U.S. Treasury securities $ 168,520 $ — $ — $ 168,520 Commercial paper — 5,956 — 5,956 Corporate bonds — 101,549 — 101,549 U.S. agency bonds — 26,199 — 26,199 Total marketable securities $ 168,520 $ 133,704 $ — $ 302,224 Total assets $ 252,798 $ 133,704 $ — $ 386,502 January 31, 2024 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 89,561 $ — $ — $ 89,561 Commercial paper — 4,991 — 4,991 Total cash equivalents $ 89,561 $ 4,991 $ — $ 94,552 Marketable securities U.S. Treasury securities $ 162,328 $ — $ — $ 162,328 Commercial paper — 11,670 — 11,670 Corporate bonds — 72,608 — 72,608 U.S. agency bonds — 36,195 — 36,195 Total marketable securities $ 162,328 $ 120,473 $ — $ 282,801 Total assets $ 251,889 $ 125,464 $ — $ 377,353 The following table summarizes the Company's investments in marketable securities on the condensed consolidated balance sheets (in thousands): July 31, 2024 Amortized Gross Gross Unrealized Losses Estimated Current Assets U.S. Treasury securities $ 168,607 $ 213 $ (300) $ 168,520 Commercial paper 5,955 1 — 5,956 Corporate bonds 100,811 756 (18) 101,549 U.S. agency bonds 26,139 60 — 26,199 Total marketable securities $ 301,512 $ 1,030 $ (318) $ 302,224 January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Current Assets U.S. Treasury securities $ 162,485 $ 85 $ (242) $ 162,328 Commercial paper 11,645 25 — 11,670 Corporate bonds 71,930 695 (17) 72,608 U.S. agency bonds 36,067 128 — 36,195 Total marketable securities $ 282,127 $ 933 $ (259) $ 282,801 The following table presents the contractual maturities of the Company’s marketable securities as of July 31, 2024 (in thousands): July 31, 2024 Amortized Cost Estimated Fair Value Due within one year $ 165,787 $ 165,733 Due within one to three years 135,725 136,491 Total $ 301,512 $ 302,224 The Company periodically evaluates its investments for expected credit losses. The Company had certain available-for-sale investment securities in a gross unrealized loss position, substantially all of which had been in such position for less than 12 months. The unrealized losses on the available-for-sale securities were primarily due to unfavorable changes in interest rates subsequent to the initial purchase of these securities. The Company expects to recover the full carrying value of its available-for-sale securities in an unrealized loss position as it does not intend or anticipate a need to sell these securities prior to recovering the associated unrealized losses. The Company also expects any credit losses would be immaterial based on the high-grade credit rating for each of such available-for-sale securities. As a result, the Company does not consider any portion of the unrealized losses as of July 31, 2024 or January 31, 2024 to represent credit losses. In April 2020 and November 2022, the Company entered into credit agreements (the “April 2020 Senior Secured Term Loan” and “November 2022 Senior Secured Credit Facility” as defined in Note 6. Debt ) with Silicon Valley Bank (“SVB”). The credit facilities are carried at amortized cost, which approximated their fair values as of July 31, 2024 and January 31, 2024. If the credit facilities were measured at fair value in the financial statements, they would be classified as Level 2 in the fair value hierarchy. The April 2020 Senior Secured Term Loan was repaid in full and terminated in November 2022. On March 27, 2023, First Citizens BancShares, Inc. announced that it entered into an agreement to purchase assets and liabilities of SVB, inclusive of the November 2022 Senior Secured Credit Facility.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, Net Property and equipment, net, consisted of the following (in thousands): July 31, 2024 January 31, 2024 Leasehold improvements $ 102,820 $ 100,795 Capitalized internal-use software 28,578 24,061 Furniture and fixtures 11,964 11,732 Desktop and other computer equipment 2,452 2,122 Construction in progress 313 326 Total gross property and equipment 146,127 139,036 Less: Accumulated depreciation and amortization (50,385) (42,493) Total property and equipment, net $ 95,742 $ 96,543 Depreciation and amortization expense was $4.3 million and $3.6 million for the three months ended July 31, 2024 and 2023, respectively, and $8.3 million and $6.9 million for the six months ended July 31, 2024 and 2023, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2024 January 31, 2024 Prepaid expenses $ 22,525 $ 25,029 Deferred contract acquisition costs, current 22,150 21,594 Other current assets 8,519 5,302 Total prepaid expenses and other current assets $ 53,194 $ 51,925 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2024 January 31, 2024 Accrued payroll liabilities $ 16,377 $ 19,219 Accrued taxes for fringe benefits 11,445 9,452 Accrued sales and value-added taxes 11,246 10,770 Accrued advertising expenses 5,850 9,276 Accrued consulting expenses 4,661 4,287 Other liabilities 23,019 22,817 Total accrued expenses and other current liabilities $ 72,598 $ 75,821

Debt

Debt	6 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt In April 2020, the Company entered into a five-year $40.0 million term loan agreement with SVB (the “April 2020 Senior Secured Term Loan”) which provided for a senior secured term loan facility, in an aggregate principal amount of up to $40.0 million to be used for the construction of the Company’s corporate headquarters. Interest accrued and was payable monthly based on a floating rate per annum equal to the prime rate (per the Wall Street Journal) plus an applicable margin ranging from 0% to (1.0)% based on the Company’s unrestricted cash balance at the lender. The April 2020 Senior Secured Term Loan was repaid in full and terminated in November 2022. In November 2022, the Company entered into an agreement for a four-year credit facility (as amended on April 13, 2023 and June 18, 2024, the “November 2022 Senior Secured Credit Facility”) with SVB, which refinanced the April 2020 Senior Secured Term Loan. The November 2022 Senior Secured Credit Facility provides for senior secured credit facilities in the aggregate principal amount of $150.0 million, including a senior secured term loan facility in an aggregate principal amount of $50.0 million and a revolving loan facility in an aggregate principal amount of up to $100.0 million, including a $30.0 million letter of credit sub-facility, maturing on November 7, 2026. On March 27, 2023, First Citizens BancShares, Inc. announced that it entered into an agreement to purchase assets and liabilities of SVB, inclusive of the November 2022 Senior Secured Credit Facility. Borrowings under the November 2022 Senior Secured Credit Facility may be designated as ABR Loans or SOFR Loans, subject to certain terms and conditions under the agreement. ABR Loans accrue interest at a rate per annum equal to the ABR plus an applicable margin of 1.25%. Term SOFR Loans accrue interest at a rate per annum equal to the applicable adjusted term SOFR rate, which is equal to the applicable term SOFR rate plus a term SOFR adjustment of 10 basis points, provided such adjusted term SOFR rate shall not be less than zero, plus an applicable margin of 2.25%. Interest accrues and is payable on a monthly basis. The November 2022 Senior Secured Credit Facility contains customary conditions to borrowing, events of default, and covenants, including covenants that restrict the Company’s ability to incur indebtedness, make or hold investments, execute certain change of control transactions, business combinations or other fundamental changes to the business, dispose of assets, make certain types of restricted payments or enter into certain related party transactions, subject to customary exceptions. In addition, the November 2022 Senior Secured Credit Facility contains financial covenants, including a consolidated adjusted quick ratio of 1.25 to 1.00, as well as a minimum cash adjusted EBITDA, each tested on a quarterly basis. Pursuant to the terms of the November 2022 Senior Secured Credit Facility, the Company may issue letters of credit which may reduce the total amount available for borrowing under the revolving credit facility. Additionally, the Company is required to pay an annual commitment fee that accrues at a rate of 0.15% per annum on the unused portion of the borrowing commitments under the revolving credit facility. The Company had an aggregate of $21.6 million of letters of credit outstanding under the revolving credit facility as of July 31, 2024, and the Company’s total available borrowing capacity under the revolving credit facility was $78.4 million as of July 31, 2024. As of July 31, 2024, $50.0 million was drawn and $45.6 million was outstanding under the November 2022 Senior Secured Credit Facility. As of July 31, 2024, the Company was in compliance with all financial covenants. In conjunction with the close of the November 2022 Senior Secured Credit Facility, the Company paid upfront issuance fees of $0.4 million. The upfront fees are amortized over the remaining term of the agreement. As of July 31, 2024, the Company had $0.2 million remaining of upfront issuance fees allocated to the revolving credit facility presented in the Company’s condensed consolidated balance sheet within other assets. The net carrying amounts of the November 2022 Senior Secured Credit Facility were as follows (in thousands): July 31, 2024 January 31, 2024 Principal $ 45,625 $ 46,875 Accrued interest 282 297 Unamortized loan issuance costs (108) (132) Net carrying amount $ 45,799 $ 47,040 Term loan, current $ 4,657 $ 3,422 Term loan, noncurrent $ 41,142 $ 43,618 The net carrying amount of the current portion of the term loan is presented within accrued expenses and other current liabilities in the condensed consolidated balance sheets. The expected future principal payments for all borrowings as of July 31, 2024 is as follows (in thousands): Fiscal year ending January 31, Expected Principal Payments Remainder of fiscal year 2025 $ 1,875 2026 5,000 2027 38,750 Total expected future principal payments $ 45,625

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Standby Letters of Credit As of July 31, 2024, the Company had several letters of credit outstanding related to its operating leases totaling $21.6 million . The letters of credit expire at various dates between 2025 and 2034. Purchase Commitments In January 2021, the Company entered into a 60-month contract with Amazon Web Services for hosting-related services. Pursuant to the terms of the contract, the Company is required to spend a minimum of $103.5 million over the term of the agreement. The commitment may be offset by up to $7.3 million in additional credits subject to the Company meeting certain conditions of the agreement, which have been earned as of July 31, 2024. As of July 31, 2024, the Company had purchase commitments remaining of $29.6 million under this contract, which are not reflected on the Company’s condensed consolidated balance sheet as of July 31, 2024. During the six months ended July 31, 2024, other than certain non-cancelable operating leases described in Note 8. Leases and the commitment for hosting-related services described above, there have been no other material changes outside the ordinary course of business to the Company's contractual obligations and commitments from those disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024. Indemnification Agreements The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against any liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. Additionally, in the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. For the six months ended July 31, 2024 and 2023, no demands have been made upon the Company to provide indemnification under such agreements, and there are no claims that the Company is aware of that could have a material adverse effect on its financial position, results of operations, or cash flows. Contingencies From time to time in the normal course of business, the Company may be subject to various claims and other legal matters arising in the ordinary course of business. As of July 31, 2024, the Company believes that none of its current legal proceedings would have a material adverse effect on its financial position, results of operations, or cash flows.

Leases

Leases	6 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Leases	Leases The Company leases real estate facilities under non-cancelable operating leases with various expiration dates through fiscal 2034. The Company has no lease agreements that are classified as finance leases. Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s total operating lease liabilities as of July 31, 2024 are as follows (in thousands): Fiscal year ending January 31, Operating Lease Payments (Net) Remainder of fiscal year 2025 $ 20,806 2026 41,715 2027 41,486 2028 39,813 2029 and thereafter 199,642 Total undiscounted operating lease payments $ 343,462 Less: imputed interest (109,407) Total operating lease liabilities $ 234,055 During the three and six months ended July 31, 2023, the Company executed a sublease for a portion of its corporate office space in San Francisco, California. The Company evaluated the associated asset group for impairment, which included the ROU assets and underlying property and equipment for the lease. The Company compared the expected future undiscounted cash flows to the carrying value and determined the respective asset group was not recoverable. The Company calculated the fair value based on the present value of the estimated cash flows from the sublease for the remaining lease term and compared the estimated fair value to its carrying value, which resulted in a $5.0 million consolidated impairment charge. The fair value of the operating lease ROU assets and associated property and equipment was estimated as of the sublease execution date using Level 3 inputs based on an income approach by converting future sublease cash inflows and outflows to a single present value. Estimated cash flows were discounted at a rate commensurate with the inherent risks associated with the asset group to arrive at an estimate of fair value. The impairment charge was included in general and administrative expenses in the condensed consolidated statements of operations. The Company recorded no impairment charge during the three and six months ended July 31, 2024. The sublease has a lease term of five years and has been classified as an operating lease by the Company. Sublease income was $0.5 million and $0.9 million for the three and six months ended July 31, 2024, respectively. There was no sublease income for the three and six months ended July 31, 2023. The Company recognizes sublease income as a reduction of lease expense in the Company’s condensed consolidated statements of operations. As of July 31, 2024, the Company has commitments of $2.4 million for an operating lease that has not yet commenced, and therefore is not included in the ROU asset or operating lease liabilities. The foregoing operating lease will commence in the fourth quarter of fiscal 2026, with a lease term of seven years. Operating lease amounts in the table above do not include sublease income payments of $8.1 million. As of July 31, 2024, the future total minimum sublease payments to be received were as follows (in thousands): Fiscal year ending January 31, Sublease Payments to be Received Remainder of fiscal year 2025 $ 943 2026 1,919 2027 1,976 2028 2,036 2029 and thereafter 1,208 Total sublease income to be received $ 8,082
Leases	Leases The Company leases real estate facilities under non-cancelable operating leases with various expiration dates through fiscal 2034. The Company has no lease agreements that are classified as finance leases. Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s total operating lease liabilities as of July 31, 2024 are as follows (in thousands): Fiscal year ending January 31, Operating Lease Payments (Net) Remainder of fiscal year 2025 $ 20,806 2026 41,715 2027 41,486 2028 39,813 2029 and thereafter 199,642 Total undiscounted operating lease payments $ 343,462 Less: imputed interest (109,407) Total operating lease liabilities $ 234,055 During the three and six months ended July 31, 2023, the Company executed a sublease for a portion of its corporate office space in San Francisco, California. The Company evaluated the associated asset group for impairment, which included the ROU assets and underlying property and equipment for the lease. The Company compared the expected future undiscounted cash flows to the carrying value and determined the respective asset group was not recoverable. The Company calculated the fair value based on the present value of the estimated cash flows from the sublease for the remaining lease term and compared the estimated fair value to its carrying value, which resulted in a $5.0 million consolidated impairment charge. The fair value of the operating lease ROU assets and associated property and equipment was estimated as of the sublease execution date using Level 3 inputs based on an income approach by converting future sublease cash inflows and outflows to a single present value. Estimated cash flows were discounted at a rate commensurate with the inherent risks associated with the asset group to arrive at an estimate of fair value. The impairment charge was included in general and administrative expenses in the condensed consolidated statements of operations. The Company recorded no impairment charge during the three and six months ended July 31, 2024. The sublease has a lease term of five years and has been classified as an operating lease by the Company. Sublease income was $0.5 million and $0.9 million for the three and six months ended July 31, 2024, respectively. There was no sublease income for the three and six months ended July 31, 2023. The Company recognizes sublease income as a reduction of lease expense in the Company’s condensed consolidated statements of operations. As of July 31, 2024, the Company has commitments of $2.4 million for an operating lease that has not yet commenced, and therefore is not included in the ROU asset or operating lease liabilities. The foregoing operating lease will commence in the fourth quarter of fiscal 2026, with a lease term of seven years. Operating lease amounts in the table above do not include sublease income payments of $8.1 million. As of July 31, 2024, the future total minimum sublease payments to be received were as follows (in thousands): Fiscal year ending January 31, Sublease Payments to be Received Remainder of fiscal year 2025 $ 943 2026 1,919 2027 1,976 2028 2,036 2029 and thereafter 1,208 Total sublease income to be received $ 8,082

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss Per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting and conversion rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net income and losses. The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Numerator: Net loss $ (72,189) $ (71,414) $ (135,911) $ (132,882) Denominator: Weighted-average shares used in calculating net loss per share, basic and diluted 229,760 219,004 228,430 217,730 Net loss per share, basic and diluted $ (0.31) $ (0.33) $ (0.59) $ (0.61) The potential shares of common stock that were excluded from the computation of diluted net loss per share for the period presented because including them would have been anti-dilutive are as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Stock options 9,114 10,541 9,114 10,541 Restricted stock units 24,138 19,312 24,138 19,312 Shares issuable pursuant to the 2020 Employee Stock Purchase Plan 362 310 362 310 Total 33,614 30,163 33,614 30,163

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock There are two classes of common stock that total 1,500,000,000 authorized shares: 1,000,000,000 authorized shares of Class A common stock and 500,000,000 authorized shares of Class B common stock. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible into one share of Class A common stock. Prior to the Direct Listing, which was completed on September 30, 2020, all 73,577,455 outstanding shares of redeemable convertible preferred stock were converted into an equivalent number of shares of Class B common stock. There are 144,002,324 shares of Class A common stock and 85,486,680 shares of Class B common stock issued and outstanding as of July 31, 2024. There were 139,238,565 shares of Class A common stock and 85,489,359 shares of Class B common stock outstanding as of January 31, 2024. All changes in the number of shares of common stock outstanding for the three and six months ended July 31, 2024 and 2023, were related to changes in Class A common stock, other than conversions of Class B common stock into an equivalent number of shares of Class A common stock. Stock Plans The Company has a 2009 Stock Plan (the “2009 Plan”), a 2012 Amended and Restated Stock Plan (the “2012 Plan”), and a 2020 Equity Incentive Plan (the “2020 Plan”). Each plan was initially established to grant equity awards to employees and consultants of the Company to assist in attracting, retaining, and motivating employees and consultants and to provide incentives to promote the success of the Company’s business. The number of shares reserved for issuance under the 2020 Plan increased by 9,414,923 shares of Class A common stock on February 1, 2022, by 10,714,637 shares of Class A common stock on February 1, 2023, and by 11,236,396 shares of Class A common stock on February 1, 2024, all pursuant to the evergreen provisions of the 2020 Plan. There are no outstanding awards under the 2009 Plan, and new issuances under the 2012 Plan terminated upon completion of the Direct Listing. Awards outstanding under the 2012 Plan continue to be outstanding and are governed by the provisions of the 2012 Plan. The 2020 Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Code, nonstatutory stock options (“NSOs”), stock appreciation rights, restricted stock awards (“RSUs”), performance-based stock awards, and other forms of equity compensation. ISOs may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees and consultants. Options under the 2020 Plan may be granted for periods of up to 10 years. The exercise price of ISOs and NSOs shall not be less than 100% of the estimated fair value of the shares on the date of grant as determined by the Company’s board of directors. Options granted generally vest over four years and vest at a rate of 25% upon the first anniversary of the vesting commencement date and 1/48 per month thereafter. The Company has outstanding RSU awards issued pursuant to the 2012 Plan and 2020 Plan. RSUs granted generally vest on a predefined rate over a period of four years contingent upon continuous service. Shares of common stock purchased under the 2012 Plan are subject to certain restrictions and repurchase rights. Stock Options Option activity under the Company’s combined stock plans is set forth below (in thousands, except years and per share data): Number of Shares Weighted- Average Exercise Price Weighted- Aggregate Intrinsic Value Balances at January 31, 2024 9,788 $ 3.09 4.2 $ 140,292 Options granted — — Options exercised (673) 3.16 Options cancelled (1) 7.49 Balances at July 31, 2024 9,114 $ 3.08 3.7 $ 104,526 Vested and exercisable at July 31, 2024 8,938 $ 3.10 3.7 $ 102,366 Vested and expected to vest at July 31, 2024 9,114 $ 3.08 3.7 $ 104,526 The total intrinsic value of options exercised during the periods presented was as follows: Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Aggregate intrinsic value of options exercised (in thousands) $ 3,285 $ 12,186 $ 7,795 $ 26,293 Early Exercise of Employee Options The 2009 Plan and 2012 Plan allow for the early exercise of stock options. The consideration received for an early exercise of an option is considered to be a deposit of the exercise price, and the related dollar amount is recorded as a liability and reflected in accrued expenses and other current liabilities and other liabilities in the condensed consolidated balance sheets. This liability is reclassified to additional paid-in capital as the awards vest. If a stock option is early exercised, the unvested shares may be repurchased by the Company in case of employment termination at the price paid by the purchaser for such shares. There were no shares that were subject to repurchase at July 31, 2024 and 384 shares subject to repurchase at July 31, 2023. Restricted Stock Units The Company’s RSU activity is set forth below (in thousands, except per share data): Number of Shares Weighted- Average Grant Date Fair Value Aggregate Intrinsic Value Unvested RSUs at January 31, 2024 17,190 $ 23.04 $ 299,450 RSUs granted 13,220 15.13 RSUs vested (4,825) 22.44 RSUs cancelled/forfeited (1,447) 21.70 Unvested RSUs at July 31, 2024 24,138 $ 18.91 $ 351,208 RSUs vested, not yet released at July 31, 2024 751 $ 32.18 Stock-Based Compensation Expense Stock-based compensation expense for stock-based awards to employees and non-employees in the Company’s condensed consolidated statements of operations for the periods below were as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Cost of revenues $ 393 $ 442 $ 676 $ 764 Research and development 34,045 31,047 60,785 54,544 Sales and marketing 17,249 16,321 32,497 27,854 General and administrative 8,420 8,395 14,789 14,541 Total stock-based compensation expense $ 60,107 $ 56,205 $ 108,747 $ 97,703 The stock-based compensation expense related to options granted to non-employees for the three and six months ended July 31, 2024 and 2023 were not material. Total unrecognized stock-based compensation expense related to unvested awards not yet recognized under all equity compensation plans was as follows: July 31, 2024 Unrecognized Expense Weighted-Average Expected Recognition Period Stock options $ 205 3.5 RSUs 421,977 3.0 Total unrecognized stock-based compensation expense $ 422,182 3.0 2020 Employee Stock Purchase Plan In September 2020, the board of directors adopted and approved the 2020 Employee Stock Purchase Plan (“ESPP”), which became effective on the effective date of the Company's registration statement on Form S-1 filed with the SEC in connection with the Direct Listing. The ESPP initially reserved and authorized the issuance of up to a total of 2,000,000 shares of Class A common stock to participating employees. The number of shares reserved under the ESPP was automatically increased on February 1, 2021 to 3,614,801 shares of Class A common stock, to 5,497,785 on February 1, 2022, to 7,640,712 on February 1, 2023, and to 9,887,991 on February 1, 2024, all pursuant to the evergreen provisions of the ESPP. Subject to any limitations contained therein, the ESPP allows eligible participants to contribute, through payroll deductions, up to 15% of their eligible compensation to purchase shares of the Company’s Class A common stock at a purchase price equal to 85% of the fair market value of the Class A common stock on either the first day of the offering period or the purchase date, whichever fair market value is lower. The ESPP generally provides for consecutive 24-month offering periods, each consisting of four separate consecutive purchase periods of approximately six months in length. The ESPP also includes a two year look back in purchase price, including a reset feature. The reset feature is triggered if the price on the date of purchase is less than the price on the first day of the offering period. The Company recognized stock-based compensation expense related to the ESPP of $2.9 million and $2.8 million during the three months ended July 31, 2024 and 2023, respectively, and $5.8 million and $3.3 million during the six months ended July 31, 2024 and 2023, respectively. As of July 31, 2024 and January 31, 2024, $4.5 million and $7.2 million, respectively, have been withheld in contributions from employees. As of July 31, 2024, total unrecognized compensation cost related to the ESPP was $8.1 million, which will be amortized over a weighted-average vesting term of 1.1 years. Stock Repurchase Program In June 2024, the Company’s board of directors authorized a stock repurchase program of up to $150.0 million of its outstanding Class A common stock. Under the program, which is designed to return value to the Company’s stockholders and reduce share count over time, the Company may repurchase shares in the open market, through privately negotiated transactions, by entering into structured repurchase agreements with third parties, by making block purchases, and/or pursuant to Rule 10b5-1 trading plans. The timing, manner, price, and amount of any repurchases under the program will be determined by the Company in its discretion. The program does not obligate the Company to acquire any particular amount of Class A common stock, and the repurchase program may be suspended or discontinued at any time at the Company’s discretion. The stock repurchase program will be funded using the Company’s working capital and is expected to continue through June 30, 2025, unless extended or shortened by the board of directors. The following table summarizes the stock repurchase activity under the Company’s stock repurchase program (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Number of shares repurchased 1,446 — 1,446 — Weighted-average price per share $ 13.64 $ — $ 13.64 $ — Aggregate purchase price $ 19,721 $ — $ 19,721 $ — As of July 31, 2024, $130.3 million remained available for future stock repurchases under the stock repurchase program. All shares of Class A common stock subsequently repurchased were retired. Upon retirement, the par value of the common stock repurchased was deducted from common stock and any excess of repurchase price over par value was recorded entirely to accumulated deficit in the condensed consolidated balance sheets.

Interest Income and Other Incom

Interest Income and Other Income (Expense), Net	6 Months Ended
	Jul. 31, 2024
Other Income and Expenses [Abstract]
Interest Income and Other Income (Expense), Net	Interest Income and Other Income (Expense), Net Interest income and other income (expense), net consist of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Interest income $ 5,409 $ 4,623 $ 10,785 $ 9,615 Unrealized gains (losses) on foreign currency transactions 1,407 (283) 882 416 Other non-operating expense (56) (175) (547) (200) Total interest income and other income (expense), net $ 6,760 $ 4,165 $ 11,120 $ 9,831 Other non-operating expense consists primarily of realized foreign currency gains and losses on transactions in the periods presented.

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company's income tax expense was $1.2 million and $1.2 million for the three months ended July 31, 2024 and 2023, respectively, and $2.2 million and $2.1 million for the six months ended July 31, 2024 and 2023, respectively, primarily due to income taxes in foreign jurisdictions.

Geographic Information

Geographic Information	6 Months Ended
	Jul. 31, 2024
Segment Reporting [Abstract]
Geographic Information	Geographic Information The following tables set forth revenues and long-lived assets, including operating lease ROU assets, by geographic area for the periods presented below (in thousands): Revenues Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 United States $ 108,232 $ 99,222 $ 212,658 $ 192,215 International 70,980 63,233 139,002 122,651 Total Revenues $ 179,212 $ 162,455 $ 351,660 $ 314,866 Revenues by geography are based on the shipping address of the customer. Long-Lived Assets July 31, 2024 January 31, 2024 United States $ 264,272 $ 271,844 International 13,731 6,430 Total long-lived assets $ 278,003 $ 278,274

Restructuring

Restructuring	6 Months Ended
	Jul. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring On November 15, 2022, the Company authorized a plan to reduce its global headcount by approximately 9%. This plan was adopted as part of a restructuring intended to improve operational efficiencies and operating costs and better align the Company’s workforce with current business needs, top strategic priorities, and key growth opportunities. The Company has completed payments associated with these restructuring charges in the six months ended July 31, 2023 and did not incur any additional restructuring costs during the three and six months ended July 31, 2024 and 2023. The following table summarizes the Company’s restructuring liabilities (in thousands): Restructuring Liability Beginning balance as of February 1, 2023 $ 873 Charges (benefit) (147) Payments (707) Foreign currency translation adjustment (19) Ending balance as of July 31, 2023 $ —

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jul. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions During the fiscal year ended January 31, 2020, the Company began leasing certain office facilities from a company affiliated with Board members of the Company. Rent expenses under these leases totaled $0.4 million and $0.4 million during the three months ended July 31, 2024 and 2023, respectively, and $0.9 million and $0.8 million during the six months ended July 31, 2024 and 2023, respectively. The Company has entered into an advertising agreement with a company affiliated with a Board member of the Company. Expenses under this agreement totaled $0.4 million and $0.5 million during the three months ended July 31, 2024 and 2023, respectively, and $1.0 million and $1.0 million during the six months ended July 31, 2024 and 2023, respectively.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Principles of Consolidation	The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and include the accounts of the Company’s wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated on consolidation.
Basis of Accounting	The unaudited condensed consolidated balance sheet as of January 31, 2024 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management's opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to state fairly the balance sheet, statements of comprehensive loss, and stockholders' equity, and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K filed with the SEC on March 14, 2024.
Use of Estimates	The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Estimates and assumptions reflected in the condensed consolidated financial statements include, but are not limited to, revenue recognition, the useful lives and carrying values of long-lived assets, the fair value of common stock for periods prior to the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“NYSE”) (the “Direct Listing”), stock-based compensation expense, the period of benefit for deferred contract acquisition costs, income taxes, and the valuation of right-of-use assets. Actual results could differ from those estimates.
Risks and Uncertainties	Global macroeconomic events including inflation, elevated interest rates, bank failures, supply chain disruptions, fluctuations in currency exchange rates, and global armed conflicts, including between Ukraine and Russia and in the Middle East, have led to economic uncertainty. These macroeconomic conditions have and are likely to continue to have adverse effects on the rate of global IT spending, including the buying patterns of the Company’s customers and prospective customers.
Concentration of Credit Risk	Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company deposits its cash and cash equivalents with financial institutions that management believes are of high credit quality, although such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Cash equivalents are invested in highly rated securities. The Company grants credit to customers in the normal course of business. For the three and six months ended July 31, 2024 and 2023, there were no individual customers that accounted for 10% or more of the Company’s revenues. No customer accounted for more than 10% of accounts receivable as of July 31, 2024 or January 31, 2024.
Fair Value of Financial Instruments	Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value is estimated by utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1—Observable inputs comprised of quoted prices for identical assets or liabilities in active markets. Level 2—Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3—Unobservable inputs in which there is little or no market data and that are significant to the fair value of the assets or liabilities. In determining fair value, a financial instrument’s classification within the three-tier fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. The carrying amount of certain financial instruments, including accounts receivable, accounts payable, and accrued liabilities approximates their fair values due to their short-term nature.
Cash, Cash Equivalents, and Restricted Cash	The Company considers all highly liquid investments with original maturities at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are stated at cost, which approximates fair value.
Available-for-sale Investments	The Company’s marketable securities are primarily comprised of U.S. government securities, commercial paper, corporate bonds, and agency bonds. The Company classifies its securities as available-for-sale at the time of purchase and reevaluates such classification at each balance sheet date. The Company may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies its marketable securities, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets. Available-for-sale securities are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity until realized. Unrealized gains and losses for any marketable securities that management intends to sell or is more likely than not that management will be required to sell prior to their anticipated recovery are recorded in other income (expense), net.
Impairment of Long-Lived Assets	The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such asset groups may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. The Company recorded no impairment charge during the three and six months ended July 31, 2024. The Company recorded an impairment charge of $5.0 million during the three and six months ended July 31, 2023, related to the right-of-use (“ROU”) assets and underlying property and equipment associated with its subleased office spaces, which is further described in Note 8. Leases to the condensed consolidated financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted	In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The new standard will be effective for the Company for the annual periods beginning February 1, 2024, and for interim periods beginning February 1, 2025. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adoption of the standard on disclosures within its consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The guidance is effective for the Company’s fiscal years beginning after February 1, 2025, with early adoption permitted. The Company is currently evaluating the impact of adoption of the standard on its consolidated financial statements.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Deferred Contract Acquisition Costs	The following table summarizes the activity of deferred contract acquisition costs (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Beginning balance $ 38,940 $ 37,338 $ 39,381 $ 36,583 Capitalization of contract acquisition costs 6,865 6,430 12,511 12,056 Amortization of deferred contract acquisition costs (6,406) (5,432) (12,493) (10,303) Ending balance $ 39,399 $ 38,336 $ 39,399 $ 38,336 Deferred contract acquisition costs, current $ 22,150 $ 20,110 $ 22,150 $ 20,110 Deferred contract acquisition costs, noncurrent 17,249 18,226 17,249 18,226 Total deferred contract acquisition costs $ 39,399 $ 38,336 $ 39,399 $ 38,336

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table summarizes, for assets measured at fair value, the respective fair value and classification by level of input within the fair value hierarchy (in thousands): July 31, 2024 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 84,278 $ — $ — $ 84,278 Total cash equivalents $ 84,278 $ — $ — $ 84,278 Marketable securities U.S. Treasury securities $ 168,520 $ — $ — $ 168,520 Commercial paper — 5,956 — 5,956 Corporate bonds — 101,549 — 101,549 U.S. agency bonds — 26,199 — 26,199 Total marketable securities $ 168,520 $ 133,704 $ — $ 302,224 Total assets $ 252,798 $ 133,704 $ — $ 386,502 January 31, 2024 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 89,561 $ — $ — $ 89,561 Commercial paper — 4,991 — 4,991 Total cash equivalents $ 89,561 $ 4,991 $ — $ 94,552 Marketable securities U.S. Treasury securities $ 162,328 $ — $ — $ 162,328 Commercial paper — 11,670 — 11,670 Corporate bonds — 72,608 — 72,608 U.S. agency bonds — 36,195 — 36,195 Total marketable securities $ 162,328 $ 120,473 $ — $ 282,801 Total assets $ 251,889 $ 125,464 $ — $ 377,353
Schedule of Debt Securities, Available-for-sale	The following table summarizes the Company's investments in marketable securities on the condensed consolidated balance sheets (in thousands): July 31, 2024 Amortized Gross Gross Unrealized Losses Estimated Current Assets U.S. Treasury securities $ 168,607 $ 213 $ (300) $ 168,520 Commercial paper 5,955 1 — 5,956 Corporate bonds 100,811 756 (18) 101,549 U.S. agency bonds 26,139 60 — 26,199 Total marketable securities $ 301,512 $ 1,030 $ (318) $ 302,224 January 31, 2024 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Current Assets U.S. Treasury securities $ 162,485 $ 85 $ (242) $ 162,328 Commercial paper 11,645 25 — 11,670 Corporate bonds 71,930 695 (17) 72,608 U.S. agency bonds 36,067 128 — 36,195 Total marketable securities $ 282,127 $ 933 $ (259) $ 282,801
Schedule of Contractual Maturities	The following table presents the contractual maturities of the Company’s marketable securities as of July 31, 2024 (in thousands): July 31, 2024 Amortized Cost Estimated Fair Value Due within one year $ 165,787 $ 165,733 Due within one to three years 135,725 136,491 Total $ 301,512 $ 302,224

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net, consisted of the following (in thousands): July 31, 2024 January 31, 2024 Leasehold improvements $ 102,820 $ 100,795 Capitalized internal-use software 28,578 24,061 Furniture and fixtures 11,964 11,732 Desktop and other computer equipment 2,452 2,122 Construction in progress 313 326 Total gross property and equipment 146,127 139,036 Less: Accumulated depreciation and amortization (50,385) (42,493) Total property and equipment, net $ 95,742 $ 96,543
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): July 31, 2024 January 31, 2024 Prepaid expenses $ 22,525 $ 25,029 Deferred contract acquisition costs, current 22,150 21,594 Other current assets 8,519 5,302 Total prepaid expenses and other current assets $ 53,194 $ 51,925
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): July 31, 2024 January 31, 2024 Accrued payroll liabilities $ 16,377 $ 19,219 Accrued taxes for fringe benefits 11,445 9,452 Accrued sales and value-added taxes 11,246 10,770 Accrued advertising expenses 5,850 9,276 Accrued consulting expenses 4,661 4,287 Other liabilities 23,019 22,817 Total accrued expenses and other current liabilities $ 72,598 $ 75,821

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The net carrying amounts of the November 2022 Senior Secured Credit Facility were as follows (in thousands): July 31, 2024 January 31, 2024 Principal $ 45,625 $ 46,875 Accrued interest 282 297 Unamortized loan issuance costs (108) (132) Net carrying amount $ 45,799 $ 47,040 Term loan, current $ 4,657 $ 3,422 Term loan, noncurrent $ 41,142 $ 43,618
Schedule of Maturities of Long-Term Debt	The expected future principal payments for all borrowings as of July 31, 2024 is as follows (in thousands): Fiscal year ending January 31, Expected Principal Payments Remainder of fiscal year 2025 $ 1,875 2026 5,000 2027 38,750 Total expected future principal payments $ 45,625

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Schedule of Operating Lease, Liability, Maturity	Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s total operating lease liabilities as of July 31, 2024 are as follows (in thousands): Fiscal year ending January 31, Operating Lease Payments (Net) Remainder of fiscal year 2025 $ 20,806 2026 41,715 2027 41,486 2028 39,813 2029 and thereafter 199,642 Total undiscounted operating lease payments $ 343,462 Less: imputed interest (109,407) Total operating lease liabilities $ 234,055
Sublease Payments to be Received	As of July 31, 2024, the future total minimum sublease payments to be received were as follows (in thousands): Fiscal year ending January 31, Sublease Payments to be Received Remainder of fiscal year 2025 $ 943 2026 1,919 2027 1,976 2028 2,036 2029 and thereafter 1,208 Total sublease income to be received $ 8,082

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Numerator: Net loss $ (72,189) $ (71,414) $ (135,911) $ (132,882) Denominator: Weighted-average shares used in calculating net loss per share, basic and diluted 229,760 219,004 228,430 217,730 Net loss per share, basic and diluted $ (0.31) $ (0.33) $ (0.59) $ (0.61)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of common stock that were excluded from the computation of diluted net loss per share for the period presented because including them would have been anti-dilutive are as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Stock options 9,114 10,541 9,114 10,541 Restricted stock units 24,138 19,312 24,138 19,312 Shares issuable pursuant to the 2020 Employee Stock Purchase Plan 362 310 362 310 Total 33,614 30,163 33,614 30,163

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Option activity under the Company’s combined stock plans is set forth below (in thousands, except years and per share data): Number of Shares Weighted- Average Exercise Price Weighted- Aggregate Intrinsic Value Balances at January 31, 2024 9,788 $ 3.09 4.2 $ 140,292 Options granted — — Options exercised (673) 3.16 Options cancelled (1) 7.49 Balances at July 31, 2024 9,114 $ 3.08 3.7 $ 104,526 Vested and exercisable at July 31, 2024 8,938 $ 3.10 3.7 $ 102,366 Vested and expected to vest at July 31, 2024 9,114 $ 3.08 3.7 $ 104,526
Summary of Weighted-Average Grant-Date Fair Value of Options Granted and Total Intrinsic Value of Options Exercised	The total intrinsic value of options exercised during the periods presented was as follows: Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Aggregate intrinsic value of options exercised (in thousands) $ 3,285 $ 12,186 $ 7,795 $ 26,293
Schedule of RSU Activity	The Company’s RSU activity is set forth below (in thousands, except per share data): Number of Shares Weighted- Average Grant Date Fair Value Aggregate Intrinsic Value Unvested RSUs at January 31, 2024 17,190 $ 23.04 $ 299,450 RSUs granted 13,220 15.13 RSUs vested (4,825) 22.44 RSUs cancelled/forfeited (1,447) 21.70 Unvested RSUs at July 31, 2024 24,138 $ 18.91 $ 351,208 RSUs vested, not yet released at July 31, 2024 751 $ 32.18
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense for stock-based awards to employees and non-employees in the Company’s condensed consolidated statements of operations for the periods below were as follows (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Cost of revenues $ 393 $ 442 $ 676 $ 764 Research and development 34,045 31,047 60,785 54,544 Sales and marketing 17,249 16,321 32,497 27,854 General and administrative 8,420 8,395 14,789 14,541 Total stock-based compensation expense $ 60,107 $ 56,205 $ 108,747 $ 97,703
Summary of Unrecognized Compensation Costs, Related to Unvested Awards	Total unrecognized stock-based compensation expense related to unvested awards not yet recognized under all equity compensation plans was as follows: July 31, 2024 Unrecognized Expense Weighted-Average Expected Recognition Period Stock options $ 205 3.5 RSUs 421,977 3.0 Total unrecognized stock-based compensation expense $ 422,182 3.0
Summary of Stock Repurchase Activity	The following table summarizes the stock repurchase activity under the Company’s stock repurchase program (in thousands, except per share data): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Number of shares repurchased 1,446 — 1,446 — Weighted-average price per share $ 13.64 $ — $ 13.64 $ — Aggregate purchase price $ 19,721 $ — $ 19,721 $ —

Interest Income and Other Inc_2

Interest Income and Other Income (Expense), Net (Tables)	6 Months Ended
	Jul. 31, 2024
Other Income and Expenses [Abstract]
Schedule of Interest and Other Income (Expense), Net	Interest income and other income (expense), net consist of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 Interest income $ 5,409 $ 4,623 $ 10,785 $ 9,615 Unrealized gains (losses) on foreign currency transactions 1,407 (283) 882 416 Other non-operating expense (56) (175) (547) (200) Total interest income and other income (expense), net $ 6,760 $ 4,165 $ 11,120 $ 9,831

Geographic Information (Tables)

Geographic Information (Tables)	6 Months Ended
	Jul. 31, 2024
Segment Reporting [Abstract]
Revenue by Geographic Areas	The following tables set forth revenues and long-lived assets, including operating lease ROU assets, by geographic area for the periods presented below (in thousands): Revenues Three Months Ended July 31, Six Months Ended July 31, 2024 2023 2024 2023 United States $ 108,232 $ 99,222 $ 212,658 $ 192,215 International 70,980 63,233 139,002 122,651 Total Revenues $ 179,212 $ 162,455 $ 351,660 $ 314,866
Long-lived Assets by Geographic Areas	Revenues by geography are based on the shipping address of the customer. Long-Lived Assets July 31, 2024 January 31, 2024 United States $ 264,272 $ 271,844 International 13,731 6,430 Total long-lived assets $ 278,003 $ 278,274

Restructuring (Tables)

Restructuring (Tables)	6 Months Ended
	Jul. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	The following table summarizes the Company’s restructuring liabilities (in thousands): Restructuring Liability Beginning balance as of February 1, 2023 $ 873 Charges (benefit) (147) Payments (707) Foreign currency translation adjustment (19) Ending balance as of July 31, 2023 $ —

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Accounting Policies [Abstract]
Restricted cash	$ 455	$ 0	$ 455	$ 0	$ 0
Impairment charge	$ 0	$ 5,000	$ 0	$ 5,000

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue recognized	$ 76.7	$ 65.6	$ 194.1	$ 166.1
Revenue, remaining performance obligation, amount	$ 394.5		$ 394.5
Deferred contract acquisition costs, amortization period	3 years		3 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	83%		83%
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months		12 months

Revenues - Deferred Contract Ac

Revenues - Deferred Contract Acquisition Costs Activity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Capitalized Contract Costs [Roll Forward]
Beginning balance	$ 38,940	$ 37,338	$ 39,381	$ 36,583
Capitalization of contract acquisition costs	6,865	6,430	12,511	12,056
Amortization of deferred contract acquisition costs	(6,406)	(5,432)	(12,493)	(10,303)
Ending balance	39,399	38,336	39,399	38,336
Deferred contract acquisition costs, current	22,150	20,110	22,150	20,110	$ 21,594
Deferred contract acquisition costs, noncurrent	17,249	18,226	17,249	18,226
Total deferred contract acquisition costs	$ 39,399	$ 38,336	$ 39,399	$ 38,336	$ 39,381

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 84,278	$ 94,552
Marketable securities	302,224	282,801
Total assets	386,502	377,353
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	84,278	89,561
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	168,520	162,328
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		4,991
Marketable securities	5,956	11,670
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	101,549	72,608
U.S. agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	26,199	36,195
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	84,278	89,561
Marketable securities	168,520	162,328
Total assets	252,798	251,889
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	84,278	89,561
Level 1 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	168,520	162,328
Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		0
Marketable securities	0	0
Level 1 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 1 | U.S. agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	4,991
Marketable securities	133,704	120,473
Total assets	133,704	125,464
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Level 2 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		4,991
Marketable securities	5,956	11,670
Level 2 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	101,549	72,608
Level 2 | U.S. agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	26,199	36,195
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Marketable securities	0	0
Total assets	0	0
Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Level 3 | U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 3 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		0
Marketable securities	0	0
Level 3 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 3 | U.S. agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 0	$ 0

Fair Value Measurements - Inves

Fair Value Measurements - Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Current assets
Amortized Cost	$ 301,512	$ 282,127
Gross Unrealized Gains	1,030	933
Gross Unrealized Losses	(318)	(259)
Estimated Fair Value	302,224	282,801
U.S. Treasury securities
Current assets
Amortized Cost	168,607	162,485
Gross Unrealized Gains	213	85
Gross Unrealized Losses	(300)	(242)
Estimated Fair Value	168,520	162,328
Commercial paper
Current assets
Amortized Cost	5,955	11,645
Gross Unrealized Gains	1	25
Gross Unrealized Losses	0	0
Estimated Fair Value	5,956	11,670
Corporate bonds
Current assets
Amortized Cost	100,811	71,930
Gross Unrealized Gains	756	695
Gross Unrealized Losses	(18)	(17)
Estimated Fair Value	101,549	72,608
U.S. agency bonds
Current assets
Amortized Cost	26,139	36,067
Gross Unrealized Gains	60	128
Gross Unrealized Losses	0	0
Estimated Fair Value	$ 26,199	$ 36,195

Fair Value Measurements - Contr

Fair Value Measurements - Contractual Maturities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Amortized Cost
Due within one year	$ 165,787
Due within one to three years	135,725
Amortized Cost	301,512
Estimated Fair Value
Due within one year	165,733
Due within one to three years	136,491
Amortized Cost	$ 302,224	$ 282,801

Balance Sheet Components - Prop

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Total gross property and equipment	$ 146,127	$ 139,036
Less: Accumulated depreciation and amortization	(50,385)	(42,493)
Total property and equipment, net	95,742	96,543
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total gross property and equipment	102,820	100,795
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total gross property and equipment	28,578	24,061
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total gross property and equipment	11,964	11,732
Desktop and other computer equipment
Property, Plant and Equipment [Line Items]
Total gross property and equipment	2,452	2,122
Construction in progress
Property, Plant and Equipment [Line Items]
Total gross property and equipment	$ 313	$ 326

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation and amortization expense	$ 4.3	$ 3.6	$ 8.3	$ 6.9

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses	$ 22,525	$ 25,029
Deferred contract acquisition costs, current	22,150	21,594	$ 20,110
Other current assets	8,519	5,302
Total prepaid expenses and other current assets	$ 53,194	$ 51,925

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued payroll liabilities	$ 16,377	$ 19,219
Accrued taxes for fringe benefits	11,445	9,452
Accrued sales and value-added taxes	11,246	10,770
Accrued advertising expenses	5,850	9,276
Accrued consulting expenses	4,661	4,287
Other liabilities	23,019	22,817
Total accrued expenses and other current liabilities	$ 72,598	$ 75,821

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended		6 Months Ended
	Nov. 30, 2022	Apr. 30, 2020	Jul. 31, 2024	Jan. 31, 2024
Line of Credit Facility [Line Items]
Line of credit, remaining borrowing capacity			$ 78,400
Debt outstanding			45,625
Debt issuance costs, net	$ 400
Credit Agreement
Line of Credit Facility [Line Items]
Debt instrument, term (in years)	4 years
Debt outstanding			45,625	$ 46,875
Debt issuance costs, net			108	$ 132
Credit Agreement | Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Debt instrument, covenant, consolidated adjusted quick ratio	1
Credit Agreement | Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Debt instrument, covenant, consolidated adjusted quick ratio	1.25
Credit Agreement | Letter of Credit
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing facility	$ 30,000
Secured Debt | Term Loan Agreement
Line of Credit Facility [Line Items]
Long-term debt, term (in years)		5 years
Long-term debt, face amount		$ 40,000
Secured Debt | Term Loan Agreement | Prime Rate | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		0%
Secured Debt | Term Loan Agreement | Prime Rate | Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		(1.00%)
Secured Debt | Credit Agreement
Line of Credit Facility [Line Items]
Proceeds from term loan, net of issuance costs			50,000
Debt outstanding			45,600
Line of Credit | Credit Agreement
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing facility	150,000
Line of Credit | Credit Agreement | Term Loan Facility
Line of Credit Facility [Line Items]
Long-term debt, face amount	$ 50,000
Debt instrument, basis spread on variable rate	2.25%
Line of Credit | Credit Agreement | Revolving Credit Facility
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing facility	$ 100,000
Line of credit facility, commitment fee percentage	0.15%
Letters of credit outstanding, amount			21,600
Debt issuance costs, net			$ 200
Line of Credit | Credit Agreement | ABR Loans
Line of Credit Facility [Line Items]
Convertible notes, interest rate, stated percentage	1.25%
Line of Credit | Credit Agreement | Secured Overnight Financing Rate (SOFR) | Term Loan Facility
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.10%

Debt - Net Carrying Amount of T

Debt - Net Carrying Amount of Term Loan (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jan. 31, 2024	Nov. 30, 2022
Debt Instrument [Line Items]
Principal	$ 45,625
Unamortized loan issuance costs			$ (400)
Credit Agreement
Debt Instrument [Line Items]
Principal	45,625	$ 46,875
Accrued interest	282	297
Unamortized loan issuance costs	(108)	(132)
Net carrying amount	45,799	47,040
Credit Agreement | Term Loan Facility
Debt Instrument [Line Items]
Term loan, current	4,657	3,422
Term loan, noncurrent	$ 41,142	$ 43,618

Debt - Schedule of Maturities o

Debt - Schedule of Maturities of Long-Term Debt (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Debt Disclosure [Abstract]
Remainder of fiscal year 2025	$ 1,875
2026	5,000
2027	38,750
Total expected future principal payments	$ 45,625

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	1 Months Ended
	Jan. 31, 2021	Jul. 31, 2024
Other Commitments [Line Items]
Long-term purchase commitment, period	60 months
Minimum spending amount	$ 103.5
Purchase commitment, maximum offsetting amount		$ 7.3
Hosting-Related Services
Other Commitments [Line Items]
Purchase commitment remaining		$ 29.6

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Leases [Abstract]
Remainder of fiscal year 2025	$ 20,806
2026	41,715
2027	41,486
2028	39,813
2029 and thereafter	199,642
Total undiscounted operating lease payments	343,462
Less: imputed interest	(109,407)
Total operating lease liabilities	$ 234,055

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Lessee, Lease, Description [Line Items]
Operating lease, impairment loss	$ 0	$ 5,000	$ 0	$ 5,000
Sublease term (in years)	5 years		5 years
Sublease income	$ 500	$ 0	$ 900	$ 0
Total sublease income to be received	$ 8,082		$ 8,082
Lessee, operating lease, lease not yet commenced, term (less than) (in years)	7 years		7 years
Operating Lease, Lease Not yet Commenced
Lessee, Lease, Description [Line Items]
Operating lease not yet commenced	$ 2,400		$ 2,400

Leases - Sublease Payments to b

Leases - Sublease Payments to be Received (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Leases [Abstract]
Remainder of fiscal year 2025	$ 943
2026	1,919
2027	1,976
2028	2,036
2029 and thereafter	1,208
Total sublease income to be received	$ 8,082

Net Loss Per Share - Basic and

Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Numerator:
Net loss	$ (72,189)	$ (71,414)	$ (135,911)	$ (132,882)
Denominator:
Weighted-average shares used in calculating net loss per share, basic (in shares)	229,760	219,004	228,430	217,730
Weighted-average shares used in calculating net loss per share, diluted (in shares)	229,760	219,004	228,430	217,730
Net loss per share, basic (in dollars per share)	$ (0.31)	$ (0.33)	$ (0.59)	$ (0.61)
Net loss per share, diluted (in dollars per share)	$ (0.31)	$ (0.33)	$ (0.59)	$ (0.61)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	33,614	30,163	33,614	30,163
Stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	9,114	10,541	9,114	10,541
Restricted stock units
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	24,138	19,312	24,138	19,312
Shares issuable pursuant to the 2020 Employee Stock Purchase Plan
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	362	310	362	310

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ in Thousands					1 Months Ended	3 Months Ended		6 Months Ended
	Feb. 01, 2024 shares	Feb. 01, 2023 shares	Feb. 01, 2022 shares	Sep. 29, 2020 shares	Sep. 30, 2020 purchasePeriod shares	Jul. 31, 2024 USD ($) stockClass shares	Jul. 31, 2023 USD ($) shares	Jul. 31, 2024 USD ($) vote stockClass shares	Jul. 31, 2023 USD ($) shares	Jan. 31, 2024 USD ($) shares	Feb. 01, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of classes of common stock | stockClass						2		2
Common stock, shares authorized (in shares)						1,500,000,000		1,500,000,000
Issuance of redeemable convertible preferred stock upon net exercise (in shares)				73,577,455
Options, period increase (decrease) (in shares)	11,236,396	10,714,637	9,414,923
Share-based compensation, options, outstanding (in shares)						9,114,000		9,114,000		9,788,000
Antidilutive securities (in shares)						33,614,000	30,163,000	33,614,000	30,163,000
Share-based payment arrangement, offering period (in months)					24 months
Stock-based compensation expense (benefit) | $						$ 60,107	$ 56,205	$ 108,747	$ 97,703
Employee contributions withheld | $						4,500		4,500		$ 7,200
Unrecognized expense | $						422,182		422,182
Stock repurchase program, authorized amount | $						$ 150,000		$ 150,000
Remaining number of shares authorized to be repurchased (in shares)						130,300,000		130,300,000
Early exercised stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Antidilutive securities (in shares)								0	384
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, options, outstanding (in shares)						0		0
Share-based compensation, options, issued (in shares)								0
Options, expiration period								10 years
Exercise price, minimum threshold, as a 100% of estimated fair value on the date of grant								100%
Vesting period								4 years
Stock options | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage								25%
Stock options | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage								2.08%
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period								4 years
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares reserved for future issuance (in shares)					2,000,000
Increase in authorized share amount (in shares)	9,887,991	7,640,712	5,497,785								3,614,801
Share-based payment arrangement, maximum employee subscription rate					15%
Purchase price of common stock, percent					85%
Share-based payment arrangement, offering period (in months)					6 months
Share-based payment arrangement, number of purchase periods | purchasePeriod					4
Share-based payment arrangement, look-back feature, term (in years)					2 years
Stock-based compensation expense (benefit) | $						$ 2,900	$ 2,800	$ 5,800	$ 3,300
Unrecognized expense | $						$ 8,100		$ 8,100
Unrecognized expense, period for recognition						1 year 1 month 6 days
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)						1,000,000,000		1,000,000,000
Number of votes (votes per share) | vote								1
Conversion of stock, shares converted (in shares)								1
Common stock, shares issued (in shares)						144,002,324		144,002,324		139,238,565
Common Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)						500,000,000		500,000,000
Number of votes (votes per share) | vote								10
Common stock, shares issued (in shares)						85,486,680		85,486,680		85,489,359

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Number of Shares
Beginning balance (in shares)			9,788
Granted (in shares)			0
Exercised (in shares)			(673)
Cancelled (in shares)			(1)
Ending balance (in shares)	9,114		9,114		9,788
Vested and exercisable, end of period (in shares)	8,938		8,938
Vested and expected to vest, end of period (in shares)	9,114		9,114
Weighted- Average Exercise Price
Beginning balance (in dollars per share)			$ 3.09
Granted (in dollars per share)			0
Exercised (in dollars per share)			3.16
Cancelled (in dollars per share)			7.49
Ending balance (in dollars per share)	$ 3.08		3.08		$ 3.09
Vested and exercisable, end of period (in dollars per share)	3.10		3.10
Vested and expected to vest, end of period (in dollars per share)	$ 3.08		$ 3.08
Weighted- Average Remaining Contractual Term (in years)
Beginning and ending (in years)			3 years 8 months 12 days		4 years 2 months 12 days
Vested and exercisable (in years)			3 years 8 months 12 days
Vested and expected to vest (in years)			3 years 8 months 12 days
Aggregate Intrinsic Value
Outstanding	$ 104,526		$ 104,526		$ 140,292
Vested and exercisable	102,366		102,366
Vested and expected to vest	104,526		104,526
Aggregate intrinsic value of options exercised (in thousands)	$ 3,285	$ 12,186	$ 7,795	$ 26,293

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of RSU Activity (Details) - Restricted stock units - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jan. 31, 2024
Number of Shares
Beginning balance (in shares)	17,190
Granted (in shares)	13,220
Vested (in shares)	(4,825)
Cancelled/forfeited (in shares)	(1,447)
Ending balance (in shares)	24,138
RSUs vested, not yet released (in shares)	751
Weighted- Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 23.04
Granted (in dollars per share)	15.13
Vested (in dollars per share)	22.44
Cancelled/forfeited (in dollars per share)	21.70
Ending balance (in dollars per share)	18.91
RSUs vested, not yet released (in dollars per share)	$ 32.18
Aggregate Intrinsic Value	$ 351,208	$ 299,450

Stockholders' Equity - Stock-ba

Stockholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 60,107	$ 56,205	$ 108,747	$ 97,703
Unrecognized expense, stock options	205		205
Unrecognized expense, RSUs	421,977		421,977
Total unrecognized stock-based compensation expense	422,182		$ 422,182
Weighted-Average Expected Recognition Period (in years)			3 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Expected Recognition Period (in years)			3 years 6 months
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Expected Recognition Period (in years)			3 years
Cost of revenues
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	393	442	$ 676	764
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	34,045	31,047	60,785	54,544
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	17,249	16,321	32,497	27,854
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 8,420	$ 8,395	$ 14,789	$ 14,541

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Repurchase Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Number of shares repurchased (in shares)	1,446	0	1,446	0
Weighted-average price per share (in usd per share)	$ 13.64	$ 0	$ 13.64	$ 0
Aggregate purchase price	$ 19,721	$ 0	$ 19,721	$ 0

Interest Income and Other Inc_3

Interest Income and Other Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Other Income and Expenses [Abstract]
Interest income	$ 5,409	$ 4,623	$ 10,785	$ 9,615
Unrealized gains (losses) on foreign currency transactions	1,407	(283)	882	416
Other non-operating expense	(56)	(175)	(547)	(200)
Total interest income and other income (expense), net	$ 6,760	$ 4,165	$ 11,120	$ 9,831

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 1,197	$ 1,228	$ 2,168	$ 2,150

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2024
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 179,212	$ 162,455	$ 351,660	$ 314,866
Long-lived assets	278,003		278,003		$ 278,274
United States
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	108,232	99,222	212,658	192,215
Long-lived assets	264,272		264,272		271,844
International
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	70,980	$ 63,233	139,002	$ 122,651
Long-lived assets	$ 13,731		$ 13,731		$ 6,430

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
	Nov. 15, 2022	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring and related cost, number of positions eliminated, period percent	9%
Restructuring costs		$ 0	$ 0	$ 0	$ 0

Restructuring - Restructuring a

Restructuring - Restructuring and Related Costs (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jan. 31, 2023
Restructuring Reserve [Roll Forward]
Beginning balance as of February 1, 2023		$ 0	$ 873
Charges (benefit)	$ (147)
Payments	(707)
Foreign currency translation adjustment	$ (19)
Ending balance as of July 31, 2023		$ 0	$ 873

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2024	Jul. 31, 2023
Lease Expense
Related Party Transaction [Line Items]
Amount of related party transactions	$ 0.4	$ 0.4	$ 0.9	$ 0.8
Advertising Agreement
Related Party Transaction [Line Items]
Amount of related party transactions	$ 0.4	$ 0.5	$ 1	$ 1